Skip to main content

Corporate insider profile

Laurence Reid Insider Trades

Latest reported as Director of Metagenomi Therapeutics, Inc. (MGX).

Purchase filings
1
Reported companies
1
Net open-market value
$23,402
Latest transaction
Sep 9, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 9, 2026Metagenomi Therapeutics, Inc. (MGX)DirectorOpen Market Purchase20,000$1.17$23,402